Eagle Pharmaceuticals, Inc. (EGRX) Social Stream
EAGLE PHARMACEUTICALS INC (EGRX) Price Targets From Analysts
Use the tables below to see what analysts covering EAGLE PHARMACEUTICALS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-09 | 4 | $52 | $46 | $49.666 | $6.01 | 726.39% |
| 2022-02-09 | 4 | $52 | $50 | $51 | $6.01 | 748.59% |
| 2022-03-31 | 4 | $50 | $49 | $49.5 | $6.01 | 723.63% |
| 2022-04-28 | 3 | $50 | $49 | $49.5 | $6.01 | 723.63% |
| 2022-06-06 | 3 | $50 | $47 | $48.5 | $6.01 | 706.99% |
| 2022-11-07 | 3 | $45 | $41 | $43 | $6.01 | 615.47% |
| 2022-11-08 | 2 | $41 | $37 | $39 | $6.01 | 548.92% |
| 2023-03-13 | 3 | $37 | $31 | $34 | $6.01 | 465.72% |
| 2023-03-14 | 3 | $33 | $31 | $32 | $6.01 | 432.45% |
| 2023-05-10 | 3 | $33 | $26 | $29.5 | $6.01 | 390.85% |
| 2023-07-25 | 2 | $26 | $26 | $26 | $6.01 | 332.61% |
| 2023-08-09 | 2 | $17 | $17 | $17 | $6.01 | 182.86% |
| NA | 1 | $NA | $NA | $NA | $6.01 | NA% |
The Trend in the Analyst Price Target
EGRX's average price target has moved down $34 over the prior 21 months.
EGRX reports an average of 26.75% for its upside potential over the past 149 days.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-13 | 3 | 37 | 31 | 34.0 | 25.51 | 33.28% |
| 2023-03-14 | 3 | 33 | 31 | 32.0 | 25.62 | 24.9% |
| 2023-05-10 | 3 | 33 | 26 | 29.5 | 21.11 | 39.74% |
| 2023-05-10 | 2 | 33 | 26 | 29.5 | 21.11 | 39.74% |
| 2023-07-25 | 2 | 26 | 26 | 26.0 | 18.36 | 41.61% |
EGRX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 3 | 1 | 0 | 0 | 1 | 1 | 2 |
The Trend in the Broker Recommendations
EGRX's average broker recommendation rating worsened by 0.75 over the prior 24 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- To contextualize these metrics, consider that out of all US stocks, EAGLE PHARMACEUTICALS INC's number of analysts covering the stock is higher than 115.23% of them.
- In the context of all US stocks, EAGLE PHARMACEUTICALS INC's variance in analysts' estimates is lower than 8.2% of them.
- In terms of how EAGLE PHARMACEUTICALS INC fares relative to stocks in the small market cap category, note that its average analyst price target is greater than 1139.6% of that group.
- EGRX has a higher upside potential (average analyst target price relative to current price) than 1139.91% of stocks in the small market cap category.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to EAGLE PHARMACEUTICALS INC are ELDN, ARDX, and LRMR.
View All Top Stocks by Price Target
Is EGRX a Buy, Hold or Sell? See the POWR Ratings now!